MYGN PEER ANALYSIS

Myriad Genetics Inc — metric-by-metric comparison with peers and the industry median

MYGNMyriad Genetics Inc

🇺🇸 USA · NASDAQ · Healthcare · Diagnostics & Research

Value it Duel

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile

MYGNIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	MYGN	HLN	TLRY	GENIL	RYM	DEVA	Ind. Median
P/E	—	31.38●	—	46.82	—	—	30.04
P/B	1.63	1.98	0.31●	3.47	0.32	0.49	3.40
EV/EBITDA	—	19.20	—	14.07	—	6.51●	20.77
P/S	0.66	3.95	0.56●	1.86	1.11	0.68	4.26

Financial Health
Metric	MYGN	HLN	TLRY	GENIL	RYM	DEVA	Ind. Median
Current Ratio	2.40	0.92	2.79●	1.33	0.55	2.00	1.87
Debt/Equity	62.7%	52.3%	20.4%●	41.0%	39.0%	23.1%	49.3%
NetDebt/EBITDA	-0.26	3.50	-0.07	1.10	-6.24●	0.89	1.92

Profitability
Metric	MYGN	HLN	TLRY	GENIL	RYM	DEVA	Ind. Median
Net Margin	-48.2%	12.6%●	-158.8%	4.0%	-60.1%	-4.4%	6.7%
ROE	-76.7%	6.3%	-63.6%	8.7%●	-16.8%	-3.6%	6.4%
ROA	-47.6%	3.2%	-49.7%	4.8%●	-5.8%	-2.5%	3.3%
EBITDA Margin	-40.3%	25.2%●	-156.2%	14.3%	-21.8%	12.0%	18.8%

Growth + Dividend
Metric	MYGN	HLN	TLRY	GENIL	RYM	DEVA	Ind. Median
Rev. Growth	-0.3%	-26.7%	3.8%	16.3%	215.1%●	7.7%	9.1%
NI Growth	—	-14.2%	—	146.6%●	—	—	12.4%
Div. Yield	—	2.0%●	—	0.0%	—	0.0%	0.8%
Payout	—	40.0%	—	0.0%	—	0.0%	23.2%

Valuation
Metric	MYGN	FLGT	CSTL	NEO	OPK	CDNA	Ind. Median
P/E	—	—	—	—	—	—	30.04
P/B	1.63	0.62	1.54	0.45●	0.94	4.80	3.40
EV/EBITDA	—	—	—	—	—	125.40	20.77
P/S	0.66	2.03	2.10	0.50●	1.95	3.64	4.26

Financial Health
Metric	MYGN	FLGT	CSTL	NEO	OPK	CDNA	Ind. Median
Current Ratio	2.40	5.31	6.75●	4.42	3.61	3.40	1.87
Debt/Equity	62.7%	1.0%●	8.0%	49.3%	33.0%	7.8%	49.3%
NetDebt/EBITDA	-0.26	4.55	310.00	-7.82	-1.59	-15.21●	1.92

Profitability
Metric	MYGN	FLGT	CSTL	NEO	OPK	CDNA	Ind. Median
Net Margin	-48.2%	-23.0%	-3.8%	-13.3%	-36.6%	-2.0%●	6.7%
ROE	-76.7%	-6.8%	-2.8%	-11.6%	-16.9%	-2.4%●	6.4%
ROA	-47.6%	-6.2%	-2.4%	-6.7%	-10.7%	-1.8%●	3.3%
EBITDA Margin	-40.3%	-18.3%	-0.2%	-4.5%	-6.0%	2.6%●	18.8%

Growth + Dividend
Metric	MYGN	FLGT	CSTL	NEO	OPK	CDNA	Ind. Median
Rev. Growth	-0.3%	9.5%	-2.1%	10.9%	-15.7%	19.2%●	9.1%
NI Growth	—	—	—	—	—	—	12.4%
Div. Yield	—	—	—	—	—	—	0.8%
Payout	—	—	—	—	—	—	23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on MYGN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.